The tweet was deleted by the author.
But we saved everything 🙂.
Expeditors International of Washington reports that USTR has announced a Section 301 investigation into Germany’s pharmaceutical pricing practices.
Further details were provided in a link shared in the announcement. Details are being clarified.
EXPD is trading at $163.15, positioned above the MA-20 ($161.73), MA-50 ($154.95), and MA-200 ($144.61), confirming established short-, medium-, and long-term bullish trends. The Ichimoku Kijun on D1 is at $158.76, which now acts as immediate support; key near-term supports are seen at MA-20 ($161.73) and MA-50 ($154.95), while near-term resistance sits at MA-10 ($163.99), with MA-100 ($151.84) offering additional support further below.
Momentum on D1 is positive, with MACD signaling a strong buy and ADX remaining neutral, suggesting the trend may lack strong conviction despite bullish signals. RSI on D1 stands at 56.69, showing mild upside momentum without overbought conditions, while Stoch RSI and BBP reflect buyer dominance but warn of emerging overbought territory. CCI is neutral, and the Awesome Oscillator does little to reinforce the current trend. Over the past week, EXPD has risen $1.83 (1.13%) from the previous weekly close of $161.32, trading in the middle of its weekly range. Weekly volatility stands at 3.44%, and current price action indicates sideway consolidation after a modest rebound from the low. In today’s session, the stock is up 1.13%, extending its firm tone within this broader consolidation.
For the week ahead, the expected trading range is $160.25 to $166.90, keeping the price well within its 52-week boundaries of $110.48 and $168.38. The probability of a further price increase is very high (more than 80%), given that all key weekly indicators—RSI, MACD, and the moving averages—are in buy territory, while the chance of a decline is very low. The baseline scenario sees EXPD moving sideways, stabilizing above support as it digests recent gains. In a bullish scenario, a clear break above $163.99 would target the upper end of the forecast range and test the $166.90 level. In a bearish scenario, sustained pressure below $161.73 could trigger a move toward stronger support at $154.95, but downside risk remains limited unless momentum deteriorates sharply.
Earlier, analysts noted that Expeditors International of Washington maintained a broadly bullish structure despite ongoing operational headwinds. This article adds a new dimension by assessing current market catalysts, with traders advised to closely monitor for any shifts in momentum that could influence the prevailing upward bias.